People Inc. (PPLI) closed its Wednesday session at $37.72, down 1.72%, before edging up to $37.73 in after‑hours trading. At the Goldman Sachs Communacopia + Technology Conference, CEO Neil Vogel described a transition from a print and digital focus to a new "brand era" aimed at monetising its extensive media portfolio.
Vogel highlighted that the company has delivered revenue growth for 11 consecutive quarters. While session‑based traffic fell more than 20% year‑over‑year and revenue from those sessions remained flat, non‑session revenue now accounts for roughly 40% to 43% of the business and is expanding at 15%‑20% each quarter.
Content production has accelerated, with the firm generating 50% more material than two years ago at comparable costs. Recipe development cycles have shrunk from a week to two‑to‑three days across 40‑50 test kitchens. The company reaches audiences through 3‑4 billion monthly emails and plans 50 brand events and 47 episodic shows.
Advertising remains a core focus. People Inc.’s D/Cipher platform can acquire third‑party ad inventory for $1 and resell it with data for $5, versus $9 for an equivalent on‑site placement. The platform targets political ads, connected TV and health/pharma sectors, with an overall ad‑market rating of 6 out of 10. Health and pharma advertisers are strong, while travel and consumer packaged goods are weaker.
Vogel also detailed licensing agreements that feed AI models at OpenAI, Microsoft and Meta, positioning People Inc. as a key source of high‑quality inputs for foundational models. He noted that Google’s single crawler for search and AI limits the company’s ability to block traffic, which now represents about 20% of its web audience, down from over 70% five years ago.
The firm is rationalising its portfolio, monetising non‑core assets such as Vivint, DeliBiz and Turo, the latter potentially pursuing an IPO. It also aims for a controlling stake—over 51%—in MGM Resorts International.
Financial metrics show a current ratio of 3.69 and a Piotroski Score of 9, underscoring solid balance‑sheet health amid the strategic shift.
